Savaria Corp (SAVA:NASDAQ)
$1.75 0.02 (1.1561%)
Analysed Savaria Corp (SAVA:NASDAQ) News Sources
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
12-03-2026
yahoo.com
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
10-03-2026
yahoo.com
Cassava Announces Closure of U.S. Department of Justice Investigation
19-02-2026
yahoo.com
Cassava Sciences And 2 Other Promising Penny Stocks
11-02-2026
yahoo.com
Cassava Technologies and AXON Networks Announce Strategic Partnership to Fuel AI Adoption and Innovation Among African Businesses
28-01-2026
yahoo.com
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
13-01-2026
yahoo.com
Sector Update: Health Care Stocks Mixed in Afternoon Trading
23-12-2025
yahoo.com
Cassava Announces Agreement to Settle Securities Class Action Litigation
23-12-2025
yahoo.com
Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session
19-12-2025
yahoo.com
Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data
19-12-2025
yahoo.com
What is the current price of Savaria Corp (SAVA:NASDAQ)?
The current price of Savaria Corp (SAVA:NASDAQ) is $1.75.
Savaria Corp (SAVA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Savaria Corp (SAVA:NASDAQ) since the previous trading day is $0.02.
Savaria Corp (SAVA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Savaria Corp (SAVA:NASDAQ) since the previous trading day is 1.1561%.
What is the most recent average sentiment score for Savaria Corp (SAVA:NASDAQ)?
The most recent average sentiment score for Savaria Corp (SAVA:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for Savaria Corp (SAVA:NASDAQ)?
The most recent sentiment for Savaria Corp (SAVA:NASDAQ) is .
SEC-8K** Filing Available For Savaria Corp (SAVA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.